腹腔镜与开腹胃切除术治疗侵犯浆膜的Siewert II/III型食管胃结合部腺癌的手术与生存结局:倾向性评分匹配分析
回顾性分析2004年1月至2015年9月单中心283例病理确诊pT4a Siewert II/III型食管胃结合部腺癌患者,经1:1倾向性评分匹配比较腹腔镜与开腹胃切除术。腹腔镜组手术时间更长但失血量更少、术后恢复更快,两组总体并发症率无显著差异,5年总生存率和无病生存率相当,复发率与复发模式无显著差异。作者认为腹腔镜胃切除术是pT4a Siewert II/III型食管胃结合部腺癌安全可行的选择。
要点
- 腹腔镜组手术时间更长,但估计失血量更少、首次排气和开始流质饮食更早、首次下床活动更早、切口更短。
- 两组总体并发症率无显著差异,腹腔镜组中转开腹率为5.4%。
- 两组5年总生存率(35.4% vs 32.1%,p=0.541)和无病生存率(34.1% vs 31.0%,p=0.523)相当,复发率与模式无显著差异。
核心结论
- 腹腔镜胃切除术治疗pT4a Siewert II/III型食管胃结合部腺癌短期结局更好,长期结局与开腹手术相似。
- 作者认为与开腹胃切除术相比,腹腔镜胃切除术是pT4a Siewert II/III型食管胃结合部腺癌安全可行的选择。
研究设计与样本
- 回顾性评估2004年1月至2015年9月单中心283例病理确诊T4a Siewert II型和III型食管胃结合部腺癌接受腹腔镜或开腹胃切除术的患者。
- 采用1:1倾向性评分匹配方法比较两组短期和长期结局。
主要发现
- 腹腔镜组手术时间更长,估计失血量更少,首次排气时间更短,开始流质饮食时间更短,首次下床活动时间更短,切口长度更短。
- 腹腔镜组中转开腹率为5.4%。
- 腹腔镜组与开腹组总体并发症率无显著差异。
- 腹腔镜组与开腹组5年总生存率分别为35.4%和32.1%(p=0.541),差异无统计学意义。
- 腹腔镜组与开腹组5年无病生存率分别为34.1%和31.0%(p=0.523),差异无统计学意义;两组复发率和复发模式无显著差异。
临床怎么用
- 原文结论认为腹腔镜胃切除术是pT4a Siewert II/III型食管胃结合部腺癌安全可行的选择,短期结局优于开腹手术且长期结局相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The potential advantage of laparoscopic gastrectomy (LG) compared with open gastrectomy (OG) for serosa-invasive (pT4a) Siewert type II and III adenocarcinoma of the esophagogastric junction (AEG) remains uncertain. Thus, the purpose of this study was to investigate the short- and long-term outcomes of LG compared to OG for pT4a Siewert type II/III AEG cancers. METHODS: We retrospectively evaluated 283 patients with pathological confirmed T4a Siewert type II and type III AEG who underwent LG or OG in our center between January 2004 and September 2015. The short- and long-term outcomes were compared between the groups using a 1:1 matched propensity score matching method (PSM). RESULTS: The LG group had a longer operation time, less estimated blood loss, less time to first flatus, less time to start liquid diet, less time to first ambulation, and shorter length of incision than the OG group. The conversion rates were 5.4% in the LG groups. There was no significant difference in the overall complication rate between the LG and OG groups. The 5-year overall survival (OS) and the 5-year disease-free survival (DFS) were comparable between the LG and OG groups (35.4% vs 32.1%, p = 0.541; 34.1% vs 31.0%, p = 0.523, respectively). There was no significant difference in the recurrence rate and pattern between the LG and OG groups. CONCLUSIONS: Laparoscopic gastrectomy is associated with better short-term outcomes and similar long-term outcomes for pT4a Siewert type II/III AEG. This study reveals that LG could be a safe and feasible option for pT4a Siewert type II/III AEG compared to OG.
引用
- Lin X, Wan J, Li Z, et al. Surgical and survival outcomes after laparoscopic and open gastrectomy for serosa-invasive Siewert type II/III esophagogastric junction carcinoma: a propensity score matching analysis. Surg Endosc. 2021. PMID: 34761283. doi:10.1007/s00464-021-08867-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。